10 Stocks Soaring Past Expectations

Ten stocks saw their share prices soar by double digits week-on-week, despite the broader market finishing with a lackluster performance, as investors continued to take path from strong corporate earnings and upbeat outlooks for the rest of the year.

In this article, we spotlight the 10 big names that led last week’s charge and detail the reasons behind their gains.

To come up with the list, we considered only the stocks with a $2 billion market capitalization and more than 5 million shares in trading volume.

The shares were chosen based on the percentage change in their share prices on October 31 and November 7.

The New York Stock Exchange building. Photo by Дмитрий Трепольский on Pexels

10. Datadog Inc. (NASDAQ:DDOG)

Datadog saw its share prices jump by 17.46 percent week-on-week, as investors took heart from the company’s higher revenue growth expectations for full-year 2025.

In an updated report earlier this week, Datadog Inc. (NASDAQ:DDOG) raised its guidance for full-year revenues to a range of $3.386 billion to $3.39 billion from the $3.312 billion to $3.322 billion previously.

Earnings per share (EPS) are likewise raised to a range of $2 to $2.02 from $1.80 to $1.83 expected earlier.

For the fourth quarter alone, Datadog Inc. (NASDAQ:DDOG) projects revenues between $912 million and $916 million, while EPS is pegged at $0.54 to $.056, assuming approximately 367 million weighted average diluted shares outstanding.

The updated outlook was encouraged by a strong revenue performance in the third quarter of the year, having incurred 28 percent higher revenues of $885.6 million versus $690 million year-on-year.

Net income, however, dwindled by 34 percent to $33.88 million from $51.70 million in the same period last year.

9. Kenvue Inc. (NYSE:KVUE)

Kenvue grew its share prices by 17.47 percent week-on-week, as investors loaded portfolios following twin news that it achieved a strong earnings performance in the past quarter of the year, alongside plans to merge with Kimberly-Clark for $48.7 billion.

In a joint statement earlier in the week, Kenvue Inc. (NYSE:KVUE) said it agreed to merge with Kimberly-Clark, under which the latter would acquire each KVUE share for $3.50 cash and 0.14625 of Kimberly-Clark shares, for a total consideration of $21.01 based on the latter’s closing price as of October 31, 2025.

The transaction is expected to combine several well-known brands under one roof, including Tylenol, Aveeno, Huggies, Kotex, Listerine, Neutrogena, Band-Aid, among others.

Meanwhile, Kenvue Inc. (NYSE:KVUE) also announced the results of its earnings performance in the third quarter of the year, during which it incurred a 4 percent jump in net income of $398 million, higher than the $383 million in the same period last year.

Net sales, however, were lower by 3.46 percent to $3.764 billion from $3.899 billion year-on-year.

For the full-year 2025, Kenvue Inc. (NYSE:KVUE) expects both net sales and organic sales to drop by low single digits, assuming approximately neutral impact from foreign currency translation.

Adjusted diluted earnings per share are expected to be in the range of $1.00 to $1.05.